Theo Wallimann: Difference between revisions
Leolaursen (talk | contribs) m Categorizing article - You can help! |
m Date the maintenance tags or general fixes |
||
| Line 1: | Line 1: | ||
{{Wikify|date=April 2008}} |
|||
{{wfy}} |
|||
'''Theo Wallimann''', PhD, Prof. was a Research Group Leader at the Institute of Cell Biology at the ETH Zurich. |
'''Theo Wallimann''', PhD, Prof. was a Research Group Leader at the Institute of Cell Biology at the ETH Zurich. |
||
| Line 10: | Line 10: | ||
His main areas of research were: The structure, function, subcellular compartmentation, as well as the regulation and molecular physiology of Creatine kinase (CK) isoenzymes and of the Creatine Transporter (CRT). The mechanisms of the observed cell & neuro-protective effects of Creatine Supplementation in health and diseases. The structure, function, regulation and molecular physiology of AMP-activated protein kinase (AMPK) that is involved in cellular energy homeostasis and nutritional signalling and thus relevant for Type-2 Diabetes, obesity, metabolic syndrome and cancer. Wallimann was the recipient of the Alfred-Vogt Price 2005. |
His main areas of research were: The structure, function, subcellular compartmentation, as well as the regulation and molecular physiology of Creatine kinase (CK) isoenzymes and of the Creatine Transporter (CRT). The mechanisms of the observed cell & neuro-protective effects of Creatine Supplementation in health and diseases. The structure, function, regulation and molecular physiology of AMP-activated protein kinase (AMPK) that is involved in cellular energy homeostasis and nutritional signalling and thus relevant for Type-2 Diabetes, obesity, metabolic syndrome and cancer. Wallimann was the recipient of the Alfred-Vogt Price 2005. |
||
==External links== |
==External links== |
||
*[http://www.cell.biol.ethz.ch/research/wallimann/publications Publications of the Wallimann group] |
*[http://www.cell.biol.ethz.ch/research/wallimann/publications Publications of the Wallimann group] |
||
*[http://icbxw.ethz.ch/creatine/creatine_supplementation.html Creatine Suppementation] |
*[http://icbxw.ethz.ch/creatine/creatine_supplementation.html Creatine Suppementation] |
||
[[Category:1946 births|Wallimann, Theo]] |
|||
[[Category:Year of death unknown|Wallimann, Theo]] |
|||
[[Category:Cell biologists]] |
[[Category:Cell biologists]] |
||
[[Category:Swiss biologists]] |
[[Category:Swiss biologists]] |
||
[[Category:Living people|Wallimann, Theo]] |
|||
Revision as of 00:31, 1 May 2008
 | Template:Wikify is deprecated. Please use a more specific cleanup template as listed in the documentation. |
Theo Wallimann, PhD, Prof. was a Research Group Leader at the Institute of Cell Biology at the ETH Zurich.
Born October 13, 1946 in Alpnach, Switzerland. he completed his dissertation at the Biology Department of the ETH Zurich in 1975 with distinction and was awarded the ETH price and medal.
From 1975-1981, he worked as a Postdoctoral Research Associate with Professor A.G. Szent-Györgyi at the Biol. Dept. of Brandeis University in Boston, Mass, U.S.A. on the subject of "myosin-linked calcium regulation of muscle contraction". In 1981, he was appointed as Senior Assistant at the Institute of Cell Biology of the ETH Zurich by Prof. H.M. Eppenberger to work in the areas of muscle biochemistry, bioenergetics and molecular physiology of creatine kinases. In 1984, he became a lecturer (with Habilitation) and in 1994, was awarded the title of Professor. He was head of the Institute of Cell Biology in the year of 1995. Prof. Theo Wallimann was retired in May 2008 and is now an Emeritus.
His main areas of research were: The structure, function, subcellular compartmentation, as well as the regulation and molecular physiology of Creatine kinase (CK) isoenzymes and of the Creatine Transporter (CRT). The mechanisms of the observed cell & neuro-protective effects of Creatine Supplementation in health and diseases. The structure, function, regulation and molecular physiology of AMP-activated protein kinase (AMPK) that is involved in cellular energy homeostasis and nutritional signalling and thus relevant for Type-2 Diabetes, obesity, metabolic syndrome and cancer. Wallimann was the recipient of the Alfred-Vogt Price 2005.